Elliot Ehrich, EVP, R&D & CMO, Alkermes, Inc at Alkermes plc. (ALKS), sold 18,000 shares at $66.81 ($1.2M) on 2015-03-16, disclosed to the SEC on 2015-03-17.
Scheduled sale ($1.2M) by EVP, R&D & CMO, Alkermes, Inc under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ALKS | SELL | 2017-02-16 | $1.2M | — | Filing → |
| ALKS | SELL | 2017-01-18 | $1.3M | — | Filing → |
| ALKS | SELL | 2017-01-06 | $618K | — | Filing → |